Bellevue Group AG
Top Portfolio Positions
154 positions ·
$4,201,462,434 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| VRTX |
Vertex Pharmaceuticals Inc / Ma
Healthcare
|
681,908 | $304,499,197 | 7.25% | |
| ARGX |
Argenx SE
Healthcare
|
313,000 | $228,568,250 | 5.44% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
278,674 | $215,314,678 | 5.12% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
3,584,573 | $176,217,608 | 4.19% | |
| GILD |
Gilead Sciences, Inc.
Healthcare
|
1,169,879 | $163,046,036 | 3.88% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
1,544,456 | $150,198,346 | 3.57% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
1,818,665 | $136,563,554 | 3.25% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
286,654 | $132,144,627 | 3.15% | |
| VRDN |
Viridian Therapeutics, Inc.DE
Healthcare
|
6,726,144 | $131,563,376 | 3.13% | |
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
481,785 | $124,454,701 | 2.96% |
Portfolio Trend
Holdings in GMED
Shares Held
Position Value (USD)
25 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,304,007 | 247,261 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $22,934,852 | 262,683 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $18,719,673 | 326,867 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $19,614,470 | 332,336 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $24,326,995 | 332,336 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $30,021,993 | 362,979 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $33,609,348 | 469,798 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $34,059,597 | 497,293 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $31,105,728 | 579,898 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $32,388,169 | 607,772 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $30,267,384 | 609,615 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $38,560,783 | 647,645 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $36,682,612 | 647,645 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $50,516,968 | 680,180 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $38,551,499 | 647,163 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $36,866,071 | 656,681 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $54,984,840 | 745,254 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $54,688,900 | 757,464 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $55,888,160 | 729,420 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $56,551,932 | 729,420 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $39,931,880 | 647,509 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $38,128,394 | 584,612 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $20,290,077 | 409,735 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $16,590,150 | 347,729 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $14,377,989 | 338,067 | Shares | Defined | 2020-05-14 | |
| No 13F history on record for this holder in this stock. | ||||||